Health Condition 1: C785- Secondary malignant neoplasm of large intestine and rectum
Conditions
Interventions
Intervention1: IV Lignocaine use during extubation: Duration of the study is one and a half year
Control Intervention1: Lignocaine instillation during extubation to see tube tolerance: Direct Instilla
Sponsors
Gujarat Cancer and Research Institute
Eligibility
Inclusion criteria
Inclusion criteria: Open abdominal and thoracic surgeries under general anesthesia
Exclusion criteria
Exclusion criteria: H/O allergy to Lignocaine Anticipated difficult airway COPD Surgery duration more than 4 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare postoperative pain scoreTimepoint: 0hr,2hr,4hr,6hr,12hr,18hr,24hrs, after infiltration | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare duration of analgesia To compare postoperative rescue analgesics requirements To compare hemodynamic To compare adverse effectTimepoint: 0hr,2hr,4hr,6hr,12hr,18hr,24hrs, after infiltration | — |
Countries
India
Contacts
Public ContactAkshiteshkumar Manubhai Gameti
Gujarat Cancer and Research Institute affiliated to BJMC Ahmedabad
Outcome results
None listed